Deborah Crouch

Array ( [id] => 690006 [patent_doc_number] => 07074454 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-11 [patent_title] => 'Production of mammary secretion antibodies in farm animals' [patent_app_type] => utility [patent_app_number] => 09/720535 [patent_app_country] => US [patent_app_date] => 2000-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 7758 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074454.pdf [firstpage_image] =>[orig_patent_app_number] => 09720535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1327181 [patent_doc_number] => 06603059 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Method of cloning animals' [patent_app_type] => B1 [patent_app_number] => 09/688782 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30145 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/603/06603059.pdf [firstpage_image] =>[orig_patent_app_number] => 09688782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1136337 [patent_doc_number] => 06780407 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Pox virus comprising DNA sequences encoding CEA and B7 antigen' [patent_app_type] => B1 [patent_app_number] => 09/663667 [patent_app_country] => US [patent_app_date] => 2000-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 73 [patent_no_of_words] => 67979 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780407.pdf [firstpage_image] =>[orig_patent_app_number] => 09663667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417384 [patent_doc_number] => 06525243 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Unactivated oocytes as cytoplast recipients of quiescent cell nuclei while maintaining correct ploidy' [patent_app_type] => B1 [patent_app_number] => 09/650285 [patent_app_country] => US [patent_app_date] => 2000-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6805 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525243.pdf [firstpage_image] =>[orig_patent_app_number] => 09650285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 872856 [patent_doc_number] => 07361804 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-22 [patent_title] => 'Unactivated oocytes in nuclear transfer to produce ungulates' [patent_app_type] => utility [patent_app_number] => 09/650194 [patent_app_country] => US [patent_app_date] => 2000-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6810 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361804.pdf [firstpage_image] =>[orig_patent_app_number] => 09650194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1422868 [patent_doc_number] => 06515197 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/648281 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 21349 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515197.pdf [firstpage_image] =>[orig_patent_app_number] => 09648281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 708296 [patent_doc_number] => 07060870 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => 'Transgenic mice over-expressing ABAD and mutant APP in brain as model of Alzheimer\'s disease and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/638647 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 23286 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060870.pdf [firstpage_image] =>[orig_patent_app_number] => 09638647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1177473 [patent_doc_number] => 06747187 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-08 [patent_title] => 'Knockout mouse for the tumor suppressor gene ANX7' [patent_app_type] => B1 [patent_app_number] => 09/633278 [patent_app_country] => US [patent_app_date] => 2000-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 52 [patent_no_of_words] => 23305 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747187.pdf [firstpage_image] =>[orig_patent_app_number] => 09633278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1146767 [patent_doc_number] => RE038556 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-07-13 [patent_title] => 'Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias' [patent_app_type] => E1 [patent_app_number] => 09/636771 [patent_app_country] => US [patent_app_date] => 2000-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 8441 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038556.pdf [firstpage_image] =>[orig_patent_app_number] => 09636771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1593969 [patent_doc_number] => 06491909 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Attenuation of rejected cells transformed with adenovirus E3' [patent_app_type] => B1 [patent_app_number] => 09/630042 [patent_app_country] => US [patent_app_date] => 2000-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 9174 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/491/06491909.pdf [firstpage_image] =>[orig_patent_app_number] => 09630042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645387 [patent_doc_number] => 06472584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Production of membrane proteins in the milk of transgenic mammals' [patent_app_type] => B1 [patent_app_number] => 09/627290 [patent_app_country] => US [patent_app_date] => 2000-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4614 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472584.pdf [firstpage_image] =>[orig_patent_app_number] => 09627290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561162 [patent_doc_number] => 06437215 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'SR-BI and ApoE knockout animals and use thereof as models for atherosclerosis and heart attack' [patent_app_type] => B1 [patent_app_number] => 09/606324 [patent_app_country] => US [patent_app_date] => 2000-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13238 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437215.pdf [firstpage_image] =>[orig_patent_app_number] => 09606324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531097 [patent_doc_number] => 06410015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Gene therapy methods using bone marrow-derived cells expressing blood clotting factors' [patent_app_type] => B1 [patent_app_number] => 09/569323 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 17 [patent_no_of_words] => 5682 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410015.pdf [firstpage_image] =>[orig_patent_app_number] => 09569323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6562036 [patent_doc_number] => 20020164782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Adenovirus vectors for gene therapy' [patent_app_type] => new [patent_app_number] => 09/568756 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 32180 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164782.pdf [firstpage_image] =>[orig_patent_app_number] => 09568756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232657 [patent_doc_number] => 07598082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-06 [patent_title] => 'Process of mammalian cell reprogramming through production of a heterokaryon' [patent_app_type] => utility [patent_app_number] => 09/980772 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12597 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598082.pdf [firstpage_image] =>[orig_patent_app_number] => 09980772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 564448 [patent_doc_number] => 07465582 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-12-16 [patent_title] => 'Nurr-1 induction of a dopaminergic neuronal fate in a neural stem cell or neural progenitor cell in vitro' [patent_app_type] => utility [patent_app_number] => 09/980913 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 13024 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465582.pdf [firstpage_image] =>[orig_patent_app_number] => 09980913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392892 [patent_doc_number] => 06537594 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Vaccina virus comprising cytokine and/or tumor associated antigen genes' [patent_app_type] => B1 [patent_app_number] => 09/535370 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 63531 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537594.pdf [firstpage_image] =>[orig_patent_app_number] => 09535370 [rel_patent_id] =>[rel_patent_doc_number] =>)